COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Emerging efficacy data have led to the emergency use authorization or approval of COVID-19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded patients with active malignancies, and thus data on the safety, tolerability and efficacy of the vaccines in patients with can...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nat Rev Clin Oncol
Hauptverfasser: Desai, Aakash, Gainor, Justin F., Hegde, Aparna, Schram, Alison M., Curigliano, Giuseppe, Pal, Sumanta, Liu, Stephen V., Halmos, Balazs, Groisberg, Roman, Grande, Enrique, Dragovich, Tomislav, Matrana, Marc, Agarwal, Neeraj, Chawla, Sant, Kato, Shumei, Morgan, Gilberto, Kasi, Pashtoon M., Solomon, Benjamin, Loong, Herbert H., Park, Haeseong, Choueiri, Toni K., Subbiah, Ishwaria M., Pemmaraju, Naveen, Subbiah, Vivek
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2021
Schlagworte:
Perspective
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957448/
https://ncbi.nlm.nih.gov/pubmed/33723371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-021-00487-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge